Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00128037
Status:
COMPLETED
Last Update Posted:
2016-09-22
First Post:
2005-08-08
Brief Title:
Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors JCOG 9806
Sponsor:
Japan Clinical Oncology Group
Organization:
Japan Clinical Oncology Group
Study Overview
Official Title:
A Phase II Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors Initial Report of Japan Clinical Oncology Group Trial JCOG 9806
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of the trimodality concurrent chemoradiotherapy followed by surgical resection approach in superior sulcus tumors
Detailed Description:
Pre-operative radiotherapy has long been the community standard in Pancoast or superior sulcus tumor However both complete resection rate -50 and long-term survival -30 are poor and unchanged for 40 years Concurrent chemoradiotherapy has been shown to be beneficial in unresectable stage III non-small cell cancer Surgery after induction chemoradiotherapy thus is a promising treatment strategy and in fact SWOG reported favorable results of this trimodality approach in superior sulcus tumor The current trial is a Japanese cooperative multi-center prospective one to evaluate its safety and efficacy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| C000000031 | None | None | None |